Ozurdex 0.7 MG implants
Ended Awarded Last action
- Contract number
- SPE2DR26FCRV8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,102
Award facts
- Contract value 100% obligated
- $4,101.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $4,101.68 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for OZURDEX 0.7 mg implants, effective January 21, 2026, with an ultimate completion date of February 11, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order will be performed at the awardee's facility in Park Ridge, Illinois.
This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a comprehensive $30.3 billion acquisition strategy. The underlying IDC, valued at $499,999,999 and awarded November 13, 2025, authorizes DLA to issue delivery orders for pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities worldwide. The company's established performance across numerous delivery orders demonstrates its capability to fulfill specialized pharmaceutical requirements within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FCRV8?
SPE2DR26FCRV8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FCRV8 worth?
The government has obligated $4,102 on SPE2DR26FCRV8.
Is contract SPE2DR26FCRV8 an order under another contract?
Yes. SPE2DR26FCRV8 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRV8 competed?
The extent of competition for SPE2DR26FCRV8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award